US90041T1088 - TPTX (XNAS)
TURNING P THERAPEUTICSCS INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 90,31 % |
Firmenprofil zu TURNING P THERAPEUTICSCS INC Aktie
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+ and NTRK+ advanced solid tumors. It also develops TPX-0022, a MET/SRC/CSF1R inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in 1/2 SWORD-1 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, an ALK inhibitor, which is in Phase 1/2 FORGE-1 study for patient with advanced or metastatic TKI-pretreated ALK-positive NSCLC. Turning Point Therapeutics, Inc. was founded in 2013 and is headquartered in San Diego, California. As of August 15, 2022, Turning Point Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Investierte Fonds
Folgende Fonds haben in TURNING P THERAPEUTICSCS INC investiert:
Fonds | Vol. in Mio 133,39 | Anteil (%) 0,31 % |
Unternehmensdaten zur TURNING P THERAPEUTICSCS INC Aktie
Name TURNING P THERAPEUTICSCS INC
Firma Turning Point Therapeutics, Inc.
Symbol TPTX
Website https://www.tptherapeutics.com
Heimatbörse
NASDAQ
ISIN US90041T1088
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Athena Maria Countouriotis
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,3 T
Adresse 10628 Science Center Dr Ste 200, 92121 San Diego
IPO Datum 2019-04-17
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | TPTX |
Weitere Aktien
Investoren die TURNING P THERAPEUTICSCS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024